Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 204Lymphoma, Large B-Cell, Diffuse 168Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Hodgkin Disease 85Lymphoma, Non-Hodgkin 79Burkitt Lymphoma 67Lymphoma, Follicular 62Leukemia 51Lymphoma, Mantle-Cell 48Lymphoma, B-Cell 33Lymphoma, Large-Cell, Anaplastic 31Lymphoma, T-Cell, Peripheral 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 25Lymphoma, Large-Cell, Immunoblastic 23Recurrence 20Lymphoma, B-Cell, Marginal Zone 17Leukemia, Lymphocytic, Chronic, B-Cell 17Immunoblastic Lymphadenopathy 17Lymphoma, T-Cell 16Neoplasms 14Dendritic Cell Sarcoma, Interdigitating 14Leukemia, Biphenotypic, Acute 10HIV Infections 10Enteropathy-Associated T-Cell Lymphoma 9Waldenstrom Macroglobulinemia 8Lymphoma, T-Cell, Cutaneous 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma, Extranodal NK-T-Cell 7Cardiotoxicity 6

Interventions

Cyclophosphamide 2varlilumab 1Vincristine 1Tomography, X-Ray Computed 1Rituximab 1Prednisone 1Nivolumab 1Interferons 1Immunoglobulin G 1Etoposide 1Echocardiography 1EPOCH protocol 1Doxorubicin 1Disulfides 1Caves 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphomatoid Granulomatosis × Doxorubicin × Lymphoid × Clear all
NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡